ALNY UP: Drug data calms nerves | Ezbrisk
By: Ezbrisk
Published:
Anomaly score: 1.612653768323035
Confidence: 0.55
Market summary
Drug data calms nerves
Ezbrisk assessment
ALNY is climbing slightly on low volatility after showcasing promising long-acting amyloid drug data at a major conference, with analysts holding steady ratings despite some price target trims, while the biotech sector broadly outperforms.
Sources: https://pharmaphorum.com/news/alnylam-showcases-long-acting-amyloid-drug-aaic, https://www.moomoo.com/news/post/74654006/stifel-maintains-alnylam-pharmaceuticals-alnyus-with-buy-rating-maintains-target, https://www.gurufocus.com/news/alny-maintains-equalweight-by-wells-fargo-price-target-lowered-to-256
Verdict ID: 1df8b83c-1e0f-426e-aa7f-e4cdc9ea597f